The Trump administration has secured another agreement forcing a major children’s hospital to stop providing gender-affirming medical care to transgender minors.
On August 5, the U.S. Department of Justice announced that Connecticut Children’s Medical Center had agreed not to provide puberty blockers, hormone therapy or gender-affirming surgeries to patients under 18.
The hospital will also pay an undisclosed monetary penalty and dedicate $500,000 in medical care to people the administration describes as suffering the “harmful consequences” of gender-affirming treatment.
Connecticut Children’s is now the third hospital to enter such an agreement with the Justice Department, following Texas Children’s Hospital and the Cleveland Clinic Foundation.
This is no longer simply a political threat or a promise buried inside an executive order.
The federal government is building a repeatable enforcement strategy capable of shutting down transgender health care—even in states where that care remains legal.
The Allegations Were Never Proven
The Justice Department says its agreement arose from a national investigation into possible violations of federal law connected to gender-affirming care for minors.
But the department’s own announcement includes a crucial qualification: the claims resolved through the agreements remain allegations. There has been no determination of liability, and Connecticut Children’s denied the allegations.
DOJ has not publicly released the Connecticut agreements, explained the amount of the hospital’s penalty or identified any judicial finding that the hospital harmed patients or violated federal law.
That distinction matters.
The administration’s press release repeatedly calls patients “victims” and describes gender-affirming care as a discredited practice. Those are the Justice Department’s characterizations—not findings established by a court.
Connecticut Children’s said the resolution allowed it to remain focused on its health-care mission while protecting patient privacy.
More Stories from QueerDispatch
“Most importantly, patient privacy remained our foremost concern throughout this process and we were able to resolve this matter without disclosing any protected patient information to the US government,” the hospital said in a statement reported by The Advocate.
That is significant amid the Justice Department’s wider campaign to obtain sensitive records concerning transgender minors and their families. Multiple federal judges have rejected or limited those demands after finding that particular subpoenas were overly broad or oppressive.
A Court Blocked One Weapon. DOJ Found Another.
Connecticut was part of a 22-jurisdiction coalition that successfully challenged the administration’s attempt to threaten hospitals with the loss of Medicare and Medicaid funding if they continued providing gender-affirming care to young people.
On March 19, a federal court granted summary judgment to the states and blocked that funding strategy. Connecticut Attorney General William Tong called the policy an illegal attempt to weaponize federal health-care money against doctors and families.
New Jersey joined that lawsuit.
But the Connecticut Children’s agreement demonstrates that defeating one legal mechanism did not end the federal campaign.
Instead of relying exclusively on threats against Medicare and Medicaid funding, DOJ has pursued allegations involving health-care billing, fraud and federal drug law. Hospitals confronted with the cost, uncertainty and institutional danger of a federal investigation may agree to stop care without the government ever proving its allegations at trial.
The administration does not need to win a sweeping court decision if it can pressure hospitals into surrendering one at a time.
That may be the most important part of this story.
From Texas to Cleveland to Connecticut
The strategy first became clear in May, when Texas Children’s Hospital entered agreements with the Justice Department and Texas Attorney General Ken Paxton.
That resolution required the hospital to end gender-affirming medical treatment for minors, pay more than $10 million in damages and penalties, and establish what officials called a “detransition clinic.”
DOJ then reached an agreement with Cleveland Clinic. Connecticut Children’s is the third institution publicly identified as part of the same national campaign.
In announcing the Connecticut agreement, Assistant Attorney General Brett Shumate explicitly connected the three cases and said the department would continue pursuing other providers.
The message to hospitals nationwide is unmistakable: providing treatment that remains lawful under state law can still bring a federal investigation, potentially ruinous legal exposure and pressure to abandon transgender patients.
For families, that creates a second layer of danger. Care can disappear even when state lawmakers have protected it and courts have blocked the administration’s broadest funding threats.
Connecticut Children’s Had Already Begun Ending Care
The settlement’s immediate practical effect is complicated by the fact that Connecticut Children’s had already announced in 2025 that it was winding down its gender-care program for patients under 19.
The hospital’s previous decision is currently being challenged by transgender patients and civil-rights advocates who argue that abruptly ending treatment violated Connecticut law.
That means the DOJ agreement may formalize and reinforce a withdrawal that was already underway. But its importance reaches beyond the patients of a single hospital.
The administration can now point to three major health systems as evidence that federal pressure works.
Each agreement also makes the next hospital more isolated. Institutions are being shown that their peers have already complied, paid penalties and adopted the administration’s preferred framework for treating former patients.
This is how access can collapse without Congress passing a national prohibition.
Deny the Care, Then Erase the Count
The hospital agreement also arrives as the administration reportedly considers restricting how the federal government collects information about LGBTQ+ people.
On August 8, WIRED reported that the Commerce Department is circulating an interagency draft rule that would bar Census questions about race and sexual orientation while excluding undocumented immigrants from the 2030 apportionment count.
That draft has not been released publicly, filed in the Federal Register or adopted as policy. The Commerce Department did not respond to WIRED’s request for comment, and the precise effect on the decennial census versus the broader American Community Survey requires further clarification.
It should therefore be treated as a reported internal proposal—not as a completed change.
But the direction is difficult to ignore.
One arm of the federal government is using investigations and settlements to push transgender patients out of major medical institutions. Another is reportedly considering rules that would make LGBTQ+ communities harder to measure.
Data collection is not symbolic. Reliable demographic information helps researchers identify disparities, governments distribute resources and civil-rights organizations demonstrate discrimination.
A government cannot honestly claim that discrimination does not exist after deliberately making the affected population more difficult to see.
The emerging pattern is not merely one of restricting rights. It is a pattern of institutional removal: remove transgender care from hospitals, remove LGBTQ+ information from federal records and then treat the resulting absence as proof that these communities and their needs were never significant.
Why This Matters in New Jersey
New Jersey has positioned itself as a safe-haven state for gender-affirming care, and lawmakers have advanced additional protections for patients and providers facing interference or legal attacks from other jurisdictions.
Those protections remain important. But the Connecticut agreement shows their limits.
A state can declare that care is legal. It can refuse to cooperate with hostile investigations from another state. It can protect records, providers and patients within its own jurisdiction.
What it cannot easily do is eliminate a hospital’s dependence on federal funding or insulate a health system from the expense and coercive weight of a Justice Department investigation.
New Jersey officials and providers should therefore treat the Connecticut settlement as a warning, not a distant development.
The question is no longer whether the federal government wants gender-affirming care to disappear. DOJ officials have said that plainly.
The question is whether hospitals in protective states will defend their patients when the threat arrives—and whether state protections are strong enough to help them do it.
The Bottom Line
Connecticut Children’s did not lose a trial establishing that its doctors committed fraud or harmed patients.
The hospital settled.
Nevertheless, the result is real: another major medical institution has agreed to stop treating transgender minors, pay the federal government and fund care built around the administration’s preferred narrative.
That is why this development matters far beyond Connecticut.
The Trump administration is demonstrating that it may not need a national ban to dismantle access to transgender health care. It can pressure hospitals individually, extract agreements and allow fear to do the rest.
And if the same government also succeeds in making LGBTQ+ people statistically invisible, documenting the consequences will become harder just when that evidence is needed most.
Read More
- New Jersey Is Back in the Fight, Challenging Trump Medicaid Ban on Trans-Youth Care
- Mount Sinai Abandons Its Young Trans Patients, Agrees to End Gender-Affirming Care
- HHS Turns Anti-Trans Report Into Federal Referral List for DOJ Investigations
- New Jersey Joins Lawsuit Against Anti-Trans Conditions on Title X Grants